Former FDA economist Nikki Tavasoli joins J.S. Held’s IP practice
Nikki Tavasoli, PhD, a former economist at the US Food and Drug Administration (FDA), has joined Ocean Tomo, the intellectual property advisory arm of J.S. Held, as a manager.
Based in the Washington metropolitan area, Tavasoli will provide economic modeling expertise for antitrust and IP damages-related matters to clients in pharma, life sciences, and healthcare disputes.
She spent the last five years at the FDA, where she was a senior economist leading data-driven investigations into drug pricing, market competition, and healthcare policy.
Tavasoli’s work included analyzing generic drug lifecycles, design opioid pricing models, and evaluating the economic and public health effects of substance bans.
She holds a PhD and master’s degree in economics from University of California, Irvine and a bachelor’s degree in economics from the University of California, Los Angeles.
“Nikki’s regulatory and economic insight strengthens our IP strategy, valuation, and expert testimony work, particularly in matters involving drug development, market entry, pricing, and litigation. Nikki’s understanding of FDA decision-making, market dynamics, and regulatory assists our clients to navigate complex legal and commercial challenges,” said James Malackowski, chief intellectual property officer at J.S. Held and co-founder of Ocean Tomo, which was acquired in 2022.
Ocean Tomo supports clients with all matter involving intangible assets, including strategic planning, investments, disputes, and transactions.
J.S. Held is headquartered in Jericho, NY and has 1,500+ people across five continents. The consulting firm has practices in technical and scientific advisory, strategic advisory, digital and data, financial investigations, valuation, and risk.
